Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
An inulin-propionate ester raised postprandial GLP-1 and PYY and reduced food intake in an overweight-adult randomized controlled trial
Your dose schedule falls apart
It is likely to increase the production of the enzyme AMPK, which improves the body's ability to use carbohydrates as an energy source
/assets/images/provider/photos/2736093.png)
This research offers further insight into this emerging safety signal, according to the study authors who noted in their Ophthalmology paper, Our novel, stratified analysis provides a more nuanced interpretation than previous pooled reviews, isolating a potential increased risk signal to observational data in the diabetes population only, a finding not corroborated by RCTs. These results are somewhat at odds with the narrative surrounding GLP-1 use and NAION risk that began in early 2024, but the researchers say they are confident in their methodology
